Biosortia Microbiomics Company
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Funding Status:
Seed
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Technology:
['BioTech & HealthTech']
Headquarters:
Dublin, Ohio, United States
Total Funding:
59000000
Last Funding Date:
2017-10-01
Last Funding Type:
Series C
Investor Type:
Inquiries@Biosortia.com
Employee Number:
11-50
Investors Number:
1.0
Founded Date:
2012-01-01